Irina Magdalena D.
- Country
- Romania
- Department
- Boli Infectioase II
Research Overview
- Phase 3 Multicenter Trial Comparing BJT-778 and Bulevirtide in Chronic Hepatitis D Infection Treatment
- A Phase 2b/3, Open-Label, Multicenter Trial Evaluating the Efficacy and Safety of Switching to Brelovitug for the Treatment of Chronic Hepatitis Delta Infection in Participants Receiving Bulevirtide (AZURE-3)
Data & Insights
Has run more than one trial at 29 of 50 partner sites.
Specializations
Infectious Disease Management
The investigator specializes in the treatment of SARS-CoV-2 infections, with particular focus on outpatient care for individuals at elevated risk of severe illness.
- COVID-19 therapeutic interventions
- High-risk patient management
- Antiviral therapy evaluation
Their research encompasses therapeutic approaches for non-hospitalized patients requiring medical attention due to COVID-19.
Clinical Risk Assessment
The investigator focuses on identifying and treating high-risk populations affected by infectious diseases in outpatient settings.
- Risk stratification protocols
- Preventive intervention strategies
- Outpatient monitoring systems
Their work involves evaluating treatment efficacy in preventing disease progression and hospitalization.
Treatment Outcomes
The investigator studies clinical outcomes in infectious disease treatment, with emphasis on preventing serious complications.
- Hospital admission prevention
- Medical intervention timing
- Treatment safety assessment
Their research evaluates therapeutic interventions' impact on reducing disease severity and improving patient outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.